Exigyn

Exigyn is a biotech and life sciences advisory firm that helps leadership teams turn science into clear strategy, credible financial plans, and compelling investor narratives. We work with early- and mid-stage biotech companies, as well as select commercial-stage pharma organizations, to solve the problems that matter most: product positioning, capital planning, valuation, and fundraising readiness. Our team is made up of former biotech operators — executives and leaders who have built, financed, and scaled life sciences companies. We don’t just advise from the outside; we work hands-on alongside founders and management teams to make decisions that are practical, defensible, and executable. What sets us apart is our tech-enabled approach. In addition to high-touch consulting, we leverage proprietary platforms — including Helix by Exigyn and AI-powered tools — to deliver dynamic planning, scenario modeling, and decision support. Our clients move beyond static decks and spreadsheets to living models that evolve with their business. We support clients across: • Strategic FP & A, budgeting, and long-range planning (SaaS platform based) • Product and science positioning • Commercial and pipeline valuation • Fundraising strategy and investor messaging • Operator-style interim and advisory support Our engagements are flexible — from focused project work to ongoing partnerships — and designed to meet companies where they are, from formation through clinical development and beyond. We help biotech teams make higher‑confidence decisions, faster — and turn strategy into momentum.